Skip to content

Minimally Invasive Surgery for Ponto Bone Anchored Hearing Implants

Minimally Invasive Surgery for Ponto Bone Anchored Hearing Implants

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02438618
Acronym
C50
Enrollment
64
Registered
2015-05-08
Start date
2014-12-02
Completion date
2018-11-18
Last updated
2019-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conductive Hearing Loss, Mixed Conductive-sensorineural Hearing Loss, Unilateral Partial Deafness

Brief summary

The objective of this study is to make a comparison between two surgical techniques used when implanting a Ponto bone anchored hearing system.

Interventions

PROCEDURESurgery for Ponto bone anchored hearing aids

Sponsors

Oticon Medical
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient, i.e. ≥ 18 years of age * Eligible for the Ponto system

Exclusion criteria

* Known history of immunosuppressive disease * Use of systemic immunosuppressive medication * Receiving bilateral bone anchored hearing system * Relevant dermatological diseases as judged by the investigator * Not being able to finish the study, for example because of failure to complete the questionnaires * Participating in another study with medical aids or medication * When there is no suitable implantation-site for the 4 mm implant during surgery because of insufficient bone quality.

Design outcomes

Primary

MeasureTime frame
Incidence of inflammation (Holgers index ≥ 2)3 months post surgery

Secondary

MeasureTime frameDescription
Soft tissue overgrowth (mm)3 months post surgery
Implant stability quotient (ISQ) measurements (ISQ units 1-100)3 months post surgery
Surgical time (minutes)3 months post surgery
Wound healing time (time to reach healed)3 months post surgery
Holgers index ≥ 2 at any time point24 months post surgery
Presence of dehiscence after surgery (present/not present)24 months post surgery
Cosmetic result (10 point scale)24 months post surgeryScored using a 10-point scale and are compared to the healthy, normal contralateral situation
Presence of dehiscence after surgery (Noted in a binary fashion (present/not present))3 months post surgery
Visual Analogue Scale (VAS) pain scale > 6 (Noted on a scale from 0 - 10)3 months post surgery
Loss of sensibility (Measured in mm outwards from the abutment)3 months post surgery
Extrusion rate (number of implants lost)3 months post surgery

Other

MeasureTime frameDescription
Quality of life related questionnaires24 months post surgery
Correlation between cytokines and Holgers index24 months post surgery
Correlation IS-pro profile and Holgers index24 months post surgery
Development of a peri-implant dermatitis scale and compare it to the Holgers Index24 months post surgery
Dynamic skin motion (analysed descriptively using photographs and computer software)3 months post surgeryOnly at main center
Skin position (analysed descriptively using photographs and computer software)3 months post surgeryOnly at main center

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026